Results 131 to 140 of about 2,667 (188)

Advances in Complement Inhibition Therapies for Paroxysmal Nocturnal Hemoglobinuria and Autoimmune Hemolytic Disorders. [PDF]

J Blood Med
Tamdin T, Rodgers GM.
europepmc   +1 more source

Iptacopan for treating paroxysmal nocturnal haemoglobinuria: A Single Technology Appraisal [PDF]

Alison, Eastwood, Anqian, Zhou, Chinyereugo, Umemneku-Chikere, Claire, Rothery, Gao, Minyue, Helen, Falbright, Mark, Rodgers, Minyue, Gao, Natalia, Kunst   +8 more
core  

First reported case of <i>Moraxella lacunata</i> bacteremia following pharyngitis in an adult with paroxysmal nocturnal hemoglobinemia receiving ravulizumab: A case report. [PDF]

IDCases
Osawa H, Shibutani K, Mori N.
europepmc   +1 more source

Long-term outcome and management of complement-mediated thrombotic microangiopathy/aHUS. [PDF]

Hematology Am Soc Hematol Educ Program
Afshar-Kharghan V.
europepmc   +1 more source

The Annual Report of the National Renal Complement Therapeutics Centre 2022/23 [PDF]

Allen G, Brocklebank V, Johnson S, Kavanagh D, Malina M, Maville C, Montgomery E, Naidoo L, Oxley A, Sheerin N, Turnbull C, Walsh P, Winn S, Wong E   +13 more
core   +1 more source

Extravascular hemolysis in PNH. [PDF]

Blood Adv
Szer J.
europepmc   +1 more source

Decrease in Urinary Tract Infections Following Switch From Anti-Interleukin-6 Monoclonal Antibody to Ravulizumab in a Patient With Neuromyelitis Optica Spectrum Disorder (NMOSD): A Case Report. [PDF]

Cureus
Takahashi S, Yasumoto T, Futamura A, Kinno R.   +3 more
europepmc   +1 more source

Gemcitabine-Induced Thrombotic Microangiopathy in a Patient With Metastatic Pancreatic Cancer: A Case Report. [PDF]

Cureus
Young J.
europepmc   +1 more source

Ravulizumab stabilizes life-threating intravascular hemolysis following delayed hemolytic transfusion reaction due to alloantibodies anti-e and anti-Jka: the first successful administration. [PDF]

Ann Hematol
Bezirgiannidou Z, Stamatiou I, Theodoridis TM, Kontekaki E, Panagiotopoulos E, Misidou C, Vrachiolias G, Malkots B, Papoutselis M, Kotsianidis I, Spanoudakis E, Liapis K.   +11 more
europepmc   +1 more source

Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report. [PDF]

BMC Nephrol
Nguyen MD, Ciurea S, Desai S, Kalebasty AR, Tran MH, Gee C, Tadros M, Nguyen VQ, Patel S, Selamet U, Hanna R.   +10 more
europepmc   +1 more source